5 medicines held by Glaxosmithkline Vaccines S.r.l. on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Bexsero 0.5 ml suspension for injection in pre-filled syringe EU/1/12/812/001-004 |
Recombinant neisseria meningitidis serogroup b nhba fusion protein, Recombinant neisseria meningitidis serogroup b nada fusion protein, Recombinant neisseria meningitidis serogroup b fhbp fusion protein, Outer rmembrane vesicles (omv) | Glaxosmithkline Vaccines S.r.l. | — |
| Menjugate 10 micrograms suspension for injection Meningococcal group C conjugate vaccine PA0919/004/003 |
Meningococcal group c oligosaccharide, Corynebacterium diphtheriae crm197 protein | Glaxosmithkline Vaccines S.r.l. | — |
| Menjugate 10 micrograms suspension for injection Meningococcal group C conjugate vaccine PA0919/004/004 |
Meningococcal group c oligosaccharide, Corynebacterium diphtheriae crm197 protein | Glaxosmithkline Vaccines S.r.l. | — |
| Menveo EU/1/10/614/002-004 |
N. MENINGITIDIS GROUP A OLIGOSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP C (STRAIN C11) POLYSACCHARIDE CONJUGATED CRM197, N. MENINGITIDIS GROUP W135 OLIGOSACCHARIDE CONJUGATED CRM197, MENINGOCOCCAL GROUP Y OLIGOSACCHARIDE CONJUGATED TO CORYNEBACTERIUM DIPHTHERIAE CRM197 PROTEIN | Glaxosmithkline Vaccines S.r.l. | — |
| Menveo powder and solution for solution for injection EU/1/10/614/002-003 |
Meningococcal group y oligosacchardie, Meningococcal group a oligosaccharide, Meningococcal group c oligosaccharide, Meningococcal group w-135 oligosaccharide | Glaxosmithkline Vaccines S.r.l. | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 21 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.